1,845
Views
7
CrossRef citations to date
0
Altmetric
Articles

Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes

, , &
Pages 191-201 | Received 15 Feb 2019, Accepted 12 Nov 2019, Published online: 07 Mar 2021

References

  • Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74–108.
  • Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases: management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236.
  • Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology. 2010;52:762–773.
  • Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321–328.
  • Lu MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054–1060.
  • Poggi G, Montagna B, DI Cesare P, et al. Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res. 2013;33:1221–1227.
  • Metcalfe MS, Mullin EJ, Texler M, et al. The safety and efficacy of radiofrequency and electrolytic ablation created adjacent to large hepatic veins in a porcine model. Eur J Surg Oncol. 2007;33:662–667.
  • Kim SH, Lim HK, Choi D, et al. Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am J Roentgenol. 2004;183:1611–1617.
  • Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43:1101–1108.
  • Kondo Y, Yoshida H, Shiina S, et al. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. Br J Surg. 2006;93:1277–1282.
  • Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003;38:977–981.
  • Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97:1253–1262.
  • Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450–458.
  • Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206–1222.
  • Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255–262.
  • Rhim H, Choi D, Kim YS, et al. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol. 2010;75:253–258.
  • Lin MX, Ye JY, Tian WS, et al. Risk factors for bile duct injury after percutaneous thermal ablation of malignant liver tumors: a retrospective case–control study. Dig Dis Sci. 2017;62:1086–1094.
  • Kondo Y, Shiina S, Tateishi R, et al. Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient’s prognosis. Liver Int. 2011;31:197–205.
  • Van Tilborg AA, Scheffer HJ, de Jong MC, et al. MWA versus MWA for perivascular and peribiliary CRLM: a retrospective patient- and lesion-based analysis of two historical cohorts. Cardiovasc Intervent Radiol. 2016;39:1438–1446.
  • Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–430.
  • Cucchetti A, Cescon M, Trevisani F, et al. Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients. World J Gastroenterol. 2012;18:6398–6408.
  • Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235:728–739.
  • Rhim H, Dodd GD, 3rd, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. RadioGraphics. 2004;24:41–52.
  • McDonald RJ, McDonald JS, Kallmes DF, et al. Behind the numbers: propensity score analysis-a primer for the diagnostic radiologist. Radiology. 2013;269:640–645.
  • Pearl J. Causality: models, reasoning, and inference. 2nd ed. Cambridge (UK): Cambridge University Press; 2009.
  • Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharmaceut Statist. 2011;10:150–161.
  • Thanos L, Mylona S, Galani P, et al. Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood vessels. Diagn Interv Radiol. 2008;14:51–56.
  • Kang TW, Lim HK, Lee MW, et al. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology. 2014;270:888–899.
  • Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–451.
  • Shibata T, Yamamoto Y, Yamamoto N, et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol. 2003;14:1535–1542.
  • Ohnishi T, Yasuda I, Nishigaki Y, et al. Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23:e410–e415.
  • Kondo Y, Yoshida H, Tateishi R, et al. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg. 2008;95:996–1004.
  • Dominique E, El Otmany A, Goharin A, et al. Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J Surg Oncol. 2001;76:297–300.
  • Wakamatsu T, Ogasawara S, Chiba T, et al. Impact of radiofrequency ablation-induced Glisson’s capsule-associated complications in patients with hepatocellular carcinoma. PLoS One. 2017;12:e0170153.
  • Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961–967.
  • Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684–692.